Gossamer Bio Inc (GOSS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.40
• Market Cap: $87.98M
• EPS: $-0.69
• 52-Week High: $3.87
• 52-Week Low: $0.33

Market Sentiment

Gossamer Bio Inc currently has a Bearish sentiment score of -0.36.

About Gossamer Bio Inc

Gossamer Bio, Inc. is a San Diego-based clinical-stage biopharmaceutical firm focused on the discovery and development of innovative therapies for immunology, inflammation, and oncology. With a robust pipeline that employs advanced scientific insights, Gossamer Bio addresses significant unmet medical needs through its diverse range of drug candidates. As it progresses through clinical trials, the company is committed to providing transformative treatment options for patients with complex dise...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Gossamer Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GOSS pay dividends?

Gossamer Bio Inc (GOSS) does not currently pay a regular dividend.

What is GOSS's market cap?

Gossamer Bio Inc (GOSS) has a market capitalization of $87.98M with a current stock price of $0.40.